20:12:23 EST Wed 30 Nov 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Avivagen Inc (2)
Symbol VIV
Shares Issued 68,484,355
Close 2022-08-02 C$ 0.155
Recent Sedar Documents

Avivagen wins 1.2-tonne OxC-beta order from AB Vista

2022-08-03 09:46 ET - News Release

Mr. Kym Anthony reports

AVIVAGEN ANNOUNCES SIGNIFICANT ORDER OF OXC-BETA IN BRAZIL

Avivagen Inc. has secured a significant order for OxC-beta from AB Vista. The 1.2-tonne order of OxC-beta will be shipped for use in Brazil, where AB Vista is running continuing trials with several large poultry and cattle producers.

"We are excited to be making further inroads into one of the world's largest feed production markets. The large size of this order is a testament to the growing demand for safe and effective alternatives to antibiotics and the market opportunity for our products," said Kym Anthony, chief executive officer of Avivagen. "We expect this important relationship with AB Vista will continue to play a significant role in the increased adoption and use of OxC-beta to promote animal health and growth in livestock throughout the Americas."

Brazil was ranked as the No. 3 feed-producing country in the world in the 2022 Alltech Agri-Food Outlook, producing 80.1 million tonnes in 2021. AB Vista is the exclusive distribution partner for OxC-beta in the United States, Brazil and Thailand.

About Avivagen Inc.

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada.

About OxC-beta technology and OxC-beta Livestock

Avivagen's OxC-beta technology is derived from Avivagen discoveries about beta-carotene and other carotenoids -- compounds that give certain fruits and vegetables their bright colours. Through support of immune function, the technology provides a non-antibiotic means of promoting health and growth. OxC-beta Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, the Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, Vietnam and Malaysia.

Avivagen's OxC-beta Livestock product is safe and effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta Livestock have proved that the product performs as well as and sometimes, in some aspects, better than in-feed antibiotics.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.